glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Cardiovascular, Kidney, and Safety Outcomes – flow trial semaglutide kidney outcomes

NICE doesnt recommend routine free T3 testing for an underactive thyroid, because your free T3 levels rarely change your treatment plan

It specifically names patients with prediabetes, early insulin resistance, or a BMI in the 25 to 29 range as candidates who may benefit from structured lifestyle intervention before pharmaceutical escalation

Does your dull complexion make you feel uncomfortable

This evolving integration of metabolic and aesthetic therapies reflects the growing importance of the aesthetic courses for doctors at HubMed Ed , which support clinicians in staying at the forefront of peptide-based interventions

Chitra Gantra explains that she's in favor of prescribing GLP-1s to adults until they're age 65 (via American Academy of Medical Colleges)